chartexchange

NeOnc Reports Additional Partial Response in Phase 2a Study of Intranasal NEO100

GlobeNewswire Inc. | Nov 17, 2026 8:00 AM EST

NeOnc Reports Additional Partial Response in Phase 2a Study of Intranasal NEO100

Read original article